Xanthurenic acid
|
Basic information |
| Metabolite name | Xanthurenic acid |
 | HMDB0000881 |
 |
C02470 |
 |
5699 |
| Synonyms | Xanthureniac acid; |
| No. of studies | 27 |
|
Basic information |
| Metabolite name | Xanthurenic acid |
| HMDB0000881 |
|
C02470 |
|
5699 |
| Synonyms | Xanthureniac acid; |
| No. of studies | 27 |
|
Relationship between Xanthurenic acid and depression (count: 27) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M008 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M012 | Type1 | CVS group vs. control group | Urine | Wistar rat | Down |
| Study M012 | Type2 | CVS + fluoxetine group vs. CVS group | Urine | Wistar rat | Up |
| Study M012 | Type2 | CVS + CSGS group vs. CVS group | Urine | Wistar rat | Up |
| Study M024 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M024 | Type2 | CUMS + high dose of Xiaoyaosan group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M046 | Type1 | LPS group vs. control group | Nucleus accumbens | C57BL/6N mouse | Up |
| Study M046 | Type1 | LPS group vs. control group | Dorsal hippocampus | C57BL/6N mouse | Up |
| Study M046 | Type1 | LPS group vs. control group | Ventral hippocampus | C57BL/6N mouse | Up |
| Study M046 | Type1 | LPS group vs. control group | Central amygdala | C57BL/6N mouse | Up |
| Study M049 | Type2 | xiaoyansan treatment 8-week vs. baseline | Urine | Human | Up |
| Study M050 | Type3 | 14h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M053 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Down |
| Study M053 | Type2 | CUMS + CSGS group vs. CUMS group | Urine | Wistar rat | Up |
| Study M068 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M101 | Type1 | CSD group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M1033 | Type1 | small intestinal bacterial overgrowth and chronic diarrhea group vs. control group | Urine | Human | Up |
| Study M1033 | Type1 | small intestinal bacterial overgrowth and chronic constipation group vs. control group | Urine | Human | Up |
| Study M1033 | Type2 | small intestinal bacterial overgrowth and chronic diarrhea group, after rifaximin treatment vs. baseline | Urine | Human | Down |
| Study M1033 | Type2 | small intestinal bacterial overgrowth and chronic constipation group, after rifaximin treatment vs. baseline | Urine | Human | Down |
| Study M1090 | Type2 | CUMS + hyperbaric oxygen treatment group vs. CUMS group | Plasma | BALb/c mouse | Up |
| Study M112 | Type5 | paroxetine-treated responder group vs. non-responder group | Hippocampus | DBA/2J mouse | Up |
| Study M516 | Type1 | SMG-treated group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M542 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M596 | Type1 | elderly depression group vs. elderly control group | Urine | Human | Up |
| Study M602 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M630 | Type2 | acupuncture + antidepressant group, post vs. before treatment | Urine | Human | Down |
| Study M633 | Type1 | corticosterone group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M672 | Type1 | SMG group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M672 | Type2 | SMG + Hemerocallis citrina extracts group vs. SMG group | Urine | Sprague-Dawley rat | Up |
| Study M672 | Type2 | SMG + paroxetine group vs. SMG group | Urine | Sprague-Dawley rat | Up |
| Study M674 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Serum | ICR mouse | Up |
| Study M701 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M724 | Type1 | MDD group vs. control group | Serum | Human | Down |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + Gleditsiae spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Down |
| Study M879 | Type1 | unipolar depression group vs. control group | Plasma | Human | Down |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Up |